These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 27487158)
1. New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents. Pimentel CB; Gurwitz JH; Tjia J; Hume AL; Lapane KL J Am Geriatr Soc; 2016 Sep; 64(9):1772-8. PubMed ID: 27487158 [TBL] [Abstract][Full Text] [Related]
2. Long-acting opioid initiation in US nursing homes. Hunnicutt JN; Hume AL; Ulbricht CM; Tjia J; Lapane KL Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):31-38. PubMed ID: 29869441 [TBL] [Abstract][Full Text] [Related]
3. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations. Ponizovsky AM; Marom E; Weizman A; Schwartzberg E Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288 [TBL] [Abstract][Full Text] [Related]
4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
5. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712 [TBL] [Abstract][Full Text] [Related]
6. [Prescription of high-potency opioids in 2011]. Hoffmann F; Glaeske G; Windt R Schmerz; 2012 Dec; 26(6):707-14. PubMed ID: 23183991 [TBL] [Abstract][Full Text] [Related]
7. Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study. Chung CP; Dupont WD; Murray KT; Hall K; Stein CM; Ray WA Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):48-53. PubMed ID: 30003613 [TBL] [Abstract][Full Text] [Related]
8. Changes in trends and pattern of strong opioid prescribing in primary care. Zin CS; Chen LC; Knaggs RD Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859 [TBL] [Abstract][Full Text] [Related]
9. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. Dosa DM; Dore DD; Mor V; Teno JM J Pain Symptom Manage; 2009 Oct; 38(4):515-21. PubMed ID: 19375273 [TBL] [Abstract][Full Text] [Related]
10. Geographic Variation in the Initiation of Commonly Used Opioids and Dosage Strength in United States Nursing Homes. Hunnicutt JN; Baek J; Alcusky M; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL Med Care; 2018 Oct; 56(10):847-854. PubMed ID: 30113423 [TBL] [Abstract][Full Text] [Related]
12. Patterns of initial opioid prescription and its association with short-term and long-term use among opioid-naïve patients in Malaysia: a retrospective cohort study. Zin CS; Nazar NI; Rahman NSA; Ahmad WR; Rani NS; Ng KS BMJ Open; 2019 Jul; 9(7):e027203. PubMed ID: 31270113 [TBL] [Abstract][Full Text] [Related]
13. A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets. Rubino M; Summers KH; Puenpatom A; Fu C; Ohsfeldt RL; Ben-Joseph RH J Manag Care Pharm; 2011 Jun; 17(5):367-76. PubMed ID: 21657806 [TBL] [Abstract][Full Text] [Related]
14. High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study. Fernandes K; Martins D; Juurlink D; Mamdani M; Paterson JM; Spooner L; Singh S; Gomes T PLoS One; 2016; 11(12):e0167479. PubMed ID: 27973601 [TBL] [Abstract][Full Text] [Related]
15. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Karanges EA; Blanch B; Buckley NA; Pearson SA Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673 [TBL] [Abstract][Full Text] [Related]
16. [Chronic non-cancer-related pain. Long-term treatment with rapid-release and short-acting opioids in the context of misuse and dependency]. Scharnagel R; Kaiser U; Schütze A; Heineck R; Gossrau G; Sabatowski R Schmerz; 2013 Feb; 27(1):7-19. PubMed ID: 23340881 [TBL] [Abstract][Full Text] [Related]
17. Opioid switch in palliative care, opioid choice by clinical need and opioid availability. Müller-Busch HC; Lindena G; Tietze K; Woskanjan S Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186 [TBL] [Abstract][Full Text] [Related]
18. Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study. Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):97-105. PubMed ID: 30421838 [TBL] [Abstract][Full Text] [Related]
19. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes. Hunnicutt JN; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL Drugs Aging; 2018 Oct; 35(10):925-936. PubMed ID: 30187291 [TBL] [Abstract][Full Text] [Related]
20. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. Ray WA; Chung CP; Murray KT; Hall K; Stein CM JAMA; 2016 Jun; 315(22):2415-23. PubMed ID: 27299617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]